Insmed’s once-daily TPIP prodrug shows sustained lung vasodilation in PAH and PH-ILD, improving walk distance, PALM outcomes, ...
Bronchiectasis appears to share genetic signals with chronic obstructive pulmonary disease (COPD), asthma, and chronic bronchitis, and a cross-ancestry genetic analysis of more than 1.8 million people ...
Cosibelimab (UNLOXCYT; Sun Pharma) received a National Comprehensive Cancer Network (NCCN) Category 2A preferred designation for patients with locally advanced cutaneous squamous cell carcinoma (CSCC) ...
As intensive care unit (ICU) admission is rarely planned, conversations about end-of-life wishes need to happen well before a ...
The study found that most surveyed individuals with obesity support lower-cost options for weight maintenance, which could ...
Clinicians are voicing growing frustration over electronic medical record (EMR) inboxes, insurance peer-to-peer calls, and ...
AMCP Nexus 2026 brings managed care leaders to San Diego October 26-29 to tackle Medicare negotiation, drug pricing policy, AI, and patient access. When managed care leaders convene in San Diego ...
A real-world trial found 42.6% of patients with severe hand eczema cleared on oral alitretinoin. Chronic hand eczema (CHE) is a debilitating dermatologic condition that often proves refractory to ...
Birth centers are unavailable in 10 states, and 39% of birth center births are self-pay, as licensing and Medicaid pay limit ...
An international eDelphi panel of 62 dermatologists agreed on a 2-step algorithm for tapering psoriasis biologics. Dose ...
Tennessee Oncology's Wade Iams, MD, MSCI, discusses staffing and tocilizumab access as barriers to expanding BiTE therapy and ...
Diagnostic delays in narcolepsy and idiopathic hypersomnia (IH) persist largely because of low awareness among patients, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results